TrivarX

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

TrivarX (formerly Medibio Limited and BioProspect Limited) is a medical technology company developing a new objective test to assist in the diagnosis of depression, other mental health disorders and chronic stress. This tests utilise circadian heart rate variability.

The technology is based on the scientific finding that circadian heart rate variability is a sensitive measure for depression and other mental health disorders and chronic stress

Contact Details

Level 4, 100 Albert Road , SOUTH MELBOURNE VIC 3205
03 9692 7222
www.medibio.com.au

Lists and Charts

Share price

Share price

TrivarX
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Revenue

Company Share Transactions

  • Company Activity

    Matt Mesnik
    		NEW ROLE: Matt Mesnik, Non-Executive Director 14 Mar 2022
    Stephen Mitchley
    		NEW ROLE: Stephen Mitchley, Non-Executive Director 22 Feb 2022
    		NEW ROLE: S Sathre, Chief Financial Officer 25 Nov 2020
    		NEW ROLE: R. E. Lees, 24 Nov 2020
    Chris Indermaur
    		REMUNERATION UPDATE: Chris Indermaur, Non-Executive Chair 03 Nov 2020
    Frank Prendergast
    		REMUNERATION UPDATE: Frank Prendergast, Non-Executive Director 03 Nov 2020
    Peter Carlisle
    		REMUNERATION UPDATE: Peter Carlisle, Non-Executive Director 03 Nov 2020
    David Kaysen
    		REMUNERATION UPDATE: David Kaysen, Chief Executive, Managing Director 03 Nov 2020

Related Information

Access to our data for TrivarX is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

TrivarX is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today